MK-1496
MK-1496 is an orally active and highly selective PLK1 inhibitor. MK-1496 exerts antitumor effects by inducing G2/M phase arrest and apoptosis in tumor cells. MK-1496 can be used in research related to parotid gland carcinoma and small cell lung cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1037254-47-9
- Formel: C14H24N2O
- Molecular Weight:236.35
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
PLK1 |
Chemical Information
-
CAS. Nr. 1037254-47-9
-
Molecular Weight 236.35
-
Formel C14H24N2O
-
SMILES
CC(C)(C)NC[C@H](C1=CC=C(C=C1)[C@@H](N)C)O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)